Subjective Global Assessment as an independent predictor of survival in patients with stage IIIB and IV non-small cell lung cancer

被引：0
|
作者：
Lammersfeld, C. [1 ]
Gupta, D. [1 ]
Dahlk, S. [1 ]
Vashi, P. G. [1 ]
Aslam, A. [1 ]
Lis, C. G. [1 ]
机构：
[1] Canc Treatment Ctr Amer, Zion, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.17552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
17552
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Tumour sphericity is an independent predictor for overall survival in non-small cell lung cancer.
    Davey, A.
    Van Herk, M.
    Faivre-Finn, C.
    McWilliam, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1083 - S1083
  • [42] Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer
    Schiller, Joan H.
    von Pawel, Joachim
    Schuett, Philipp
    Ansari, Rafat H.
    Thomas, Michael
    Saleh, Mansoor
    McCroskey, Robert D.
    Pfeifer, Wolfgang
    Marsland, Thomas A.
    Kloecker, Goetz H.
    Sebastian, Martin
    Pirker, Robert
    Kurek, Raffael
    Beadman, Claire
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : 1977 - 1985
  • [43] Outcomes Of Elderly Patients With Stage IIIB-IV Non-Small Cell Lung Cancer Admitted To The Intensive Care Unit
    Smith, C. B.
    Bonomi, M.
    Mhango, G.
    Wisnivesky, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [44] Outcomes of elderly patients with stage IIIB-IV non-small cell lung cancer admitted to the intensive care unit
    Bonomi, Marcelo R.
    Smith, Cardinale B.
    Mhango, Grace
    Wisnivesky, Juan P.
    LUNG CANCER, 2012, 77 (03) : 600 - 604
  • [45] A Phase II Study of Erlotinib as Initial Treatment for Patients with Stage IIIB-IV Non-small Cell Lung Cancer
    Akerley, Wallace
    Boucher, Kenneth M.
    Bentz, Joel S.
    Arbogast, Kylee
    Walters, Theodore
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) : 214 - 219
  • [46] Advanced radiotherapy techniques in stage IIIB non-small cell lung cancer
    Price, Allan
    Reilly, Andrew
    Erridge, Sara C.
    EJC SUPPLEMENTS, 2007, 5 (05): : 269 - 276
  • [47] A phase I study of paclitaxel in combination with etoposide in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
    Ukena, D
    Berg, M
    Leutz, M
    Zell, L
    Schlimmer, P
    Sybrecht, GW
    LUNG CANCER, 1998, 19 (01) : 31 - 36
  • [48] Irinotecan and docetaxel as first-line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer.
    Raez, LE
    Rosado, M
    Santos, ES
    Hamilton, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 677S - 677S
  • [49] Perioperative chemoimmunotherapy in a patient with stage IIIB non-small cell lung cancer
    Liang, Hengrui
    Deng, Hongsheng
    Liang, Wenhua
    Guo, Kai
    Gao, Ziqing
    Wiesel, Ory
    Flores, Raja M.
    Song, Kimberly
    Redwan, Bassam
    Migliore, Marcello
    Li, Shuben
    Yin, Weiqiang
    He, Jianxing
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (05)
  • [50] Subjective Global Assessment is an Independent Predictor of Survival in Dialysis Patients
    Lajili, F. A.
    Turner, A. N.
    Elliot, H.
    Metcalfe, W.
    SCOTTISH MEDICAL JOURNAL, 2008, 53 (04) : 53 - 53
12345